Aceglatone
A chemical compound used in cancer treatment
| Aceglatone | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Aceglatone is a chemical compound that has been studied for its potential use in the treatment of cancer. It is known for its role as an inhibitor of the enzyme beta-glucuronidase, which is involved in the metabolism of certain drugs and endogenous compounds.
Chemical Properties
Aceglatone is an ester derivative of phenol, specifically a phenyl acetate. Its chemical structure includes a phenyl ring with an acetate group and an ethoxy group attached, which contributes to its biological activity.
Mechanism of Action
Aceglatone functions primarily as a beta-glucuronidase inhibitor. This enzyme is responsible for the hydrolysis of glucuronides, which are conjugated metabolites of various substances, including drugs and hormones. By inhibiting beta-glucuronidase, aceglatone can affect the metabolism and excretion of these compounds, potentially enhancing the efficacy of certain chemotherapeutic agents.
Clinical Applications
While aceglatone has been investigated for its potential in cancer therapy, its clinical use is not widespread. Research has focused on its ability to modulate drug metabolism and improve the therapeutic index of anticancer drugs. However, further studies are needed to fully establish its efficacy and safety in clinical settings.
Pharmacokinetics
The pharmacokinetic profile of aceglatone involves its absorption, distribution, metabolism, and excretion. As an ester, it may undergo hydrolysis in the body to release the active phenolic compound, which can then exert its inhibitory effects on beta-glucuronidase.
Safety and Side Effects
The safety profile of aceglatone is not well-documented, as it is not widely used in clinical practice. Potential side effects would likely be related to its mechanism of action and its impact on drug metabolism.
Research and Development
Ongoing research is exploring the potential of aceglatone in combination with other anticancer agents. Its role in modulating drug metabolism makes it a candidate for enhancing the effectiveness of chemotherapy regimens.
Related pages
Gallery
-
Chemical structure of Aceglatone
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
